In fast-moving, high-pressure mergers, acquisitions, partnering, and investment transactions, obtaining an accurate and comprehensive intellectual property evaluation is critical. The possible outcome of pending or potential litigation, the assignability of a company’s IP agreements, and the scope and ownership of IP rights are just some of the issues to consider.
Our deep understanding of varied technologies and mastery of IP law allow us to help companies react quickly to any issue that emerges during an IP transaction, to provide thoughtful and accurate answers to investors’ questions, and to craft contract terms that properly allocate risks. We deliver highly targeted and sophisticated analyses of the IP assets at issue that can help drive an equitable deal.
We have conducted successful due diligence on matters as complex as the Exxon–Mobil merger, and as focused as an analysis of in-license agreements of an innovative biotech start-up that was being considered for later-round funding. Our size, technical background, and experience allow us to assemble and mobilize a well matched team that quickly identifies key issues, proposes options for mitigating risks, and outlines a strategy for strengthening our client’s bargaining position. Ideally, due diligence investigations are conducted at the onset of negotiations, allowing time for a reasoned analysis of the value of the IP portfolio and time for corrective action to address issues that may influence the deal.
Oversaw due diligence for one of the world’s largest chemical companies while it was purchasing another company, including overseeing the mapping and analysis of the target’s patent portfolio and analyzing potential infringement by competitors.
Workshop
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law
May 2, 2024
Cambridge
Conference
2nd Annual Forum on IP, Funding and Tech Strategies for Novel Therapeutic Modalities
March 20, 2024
Boston
Lecture
IP (Intellectual Property) Due Diligence & Freedom to Operate in Practice Training Course
March 7-8, 2024
Virtual
Articles
How to Avoid Common Pitfalls and Protect IP in Today’s Life Sciences Industry Joint Ventures
February 29, 2024
Webinar
January 11, 2024
Webinar
Commentary
April 11, 2024
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.